Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VEEV · against 61 other Healthcare companies of similar size
Ranked #11 of 62 · scores higher than 84% of peers · safety percentile 73
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)5 peers with a safety percentile of 70–79, including VEEV · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VEEV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 59 reported | 0.02× | 0.50× | 93% | 33% | |
| BetaLower is better · 59 reported | 0.97 | 0.71 | 22% | 33% | |
| Current ratioHigher is better · 59 reported | 5.46× | 1.80× | 93% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 7 | 4.25T INR (≈$51.0B) | 81 | 70 | |
| 8 | 41.6B USD | 79 | 34 | |
| 9 | 193.6B HKD (≈$24.8B) | 76 | 78 | |
| 10 | 11.26T JPY (≈$76.6B) | 74 | 72 | |
| 11 | 49.1B USD | 73 | 69 | |
| 12 | 225.2B CNY (≈$31.5B) | 73 | 63 | |
| 13 | 54.9B USD | 68 | 59 | |
| 14 | 67.60T KRW (≈$48.7B) | 64 | 72 | |
| 15 | 40.2B USD | 62 | 73 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score